| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytokine receptor activity | 3.00e-06 | 97 | 128 | 7 | GO:0004896 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.07e-05 | 130 | 128 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | cytokine binding | 6.93e-05 | 157 | 128 | 7 | GO:0019955 | |
| GeneOntologyMolecularFunction | immune receptor activity | 9.47e-05 | 165 | 128 | 7 | GO:0140375 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine-6-sulfatase activity | 1.22e-04 | 3 | 128 | 2 | GO:0008449 | |
| GeneOntologyMolecularFunction | 1-acylglycerophosphoserine O-acyltransferase activity | 2.43e-04 | 4 | 128 | 2 | GO:0106263 | |
| GeneOntologyMolecularFunction | 1-acylglycerophosphoethanolamine O-acyltransferase activity | 2.43e-04 | 4 | 128 | 2 | GO:0106262 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 6.01e-04 | 26 | 128 | 3 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 6.01e-04 | 26 | 128 | 3 | GO:0004950 | |
| GeneOntologyMolecularFunction | creatine kinase activity | 6.01e-04 | 6 | 128 | 2 | GO:0004111 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 8.28e-04 | 171 | 128 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, nitrogenous group as acceptor | 1.11e-03 | 8 | 128 | 2 | GO:0016775 | |
| GeneOntologyMolecularFunction | 1-acylglycerophosphocholine O-acyltransferase activity | 1.11e-03 | 8 | 128 | 2 | GO:0047184 | |
| GeneOntologyMolecularFunction | chemokine binding | 1.22e-03 | 33 | 128 | 3 | GO:0019956 | |
| GeneOntologyMolecularFunction | deaminase activity | 1.33e-03 | 34 | 128 | 3 | GO:0019239 | |
| GeneOntologyMolecularFunction | 2-acylglycerol-3-phosphate O-acyltransferase activity | 1.43e-03 | 9 | 128 | 2 | GO:0047144 | |
| Domain | Alpha_tubulin | 7.60e-12 | 9 | 128 | 6 | IPR002452 | |
| Domain | Tubulin_C | 6.28e-09 | 22 | 128 | 6 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 6.28e-09 | 22 | 128 | 6 | IPR018316 | |
| Domain | Tubulin_C | 6.28e-09 | 22 | 128 | 6 | SM00865 | |
| Domain | Tub_FtsZ_C | 8.45e-09 | 23 | 128 | 6 | IPR008280 | |
| Domain | Tubulin_C | 8.45e-09 | 23 | 128 | 6 | IPR023123 | |
| Domain | TUBULIN | 8.45e-09 | 23 | 128 | 6 | PS00227 | |
| Domain | Tubulin | 8.45e-09 | 23 | 128 | 6 | IPR000217 | |
| Domain | Tubulin | 8.45e-09 | 23 | 128 | 6 | SM00864 | |
| Domain | Tubulin_CS | 8.45e-09 | 23 | 128 | 6 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 1.12e-08 | 24 | 128 | 6 | IPR003008 | |
| Domain | Tubulin | 1.12e-08 | 24 | 128 | 6 | PF00091 | |
| Domain | - | 2.00e-07 | 20 | 128 | 5 | 3.30.1330.20 | |
| Domain | - | 2.60e-07 | 21 | 128 | 5 | 1.10.287.600 | |
| Domain | - | 3.35e-07 | 22 | 128 | 5 | 3.40.50.1440 | |
| Domain | Extracellular_sulfatase | 4.66e-05 | 2 | 128 | 2 | IPR014615 | |
| Domain | Osteonectin_CS | 4.66e-05 | 2 | 128 | 2 | IPR001999 | |
| Domain | Extracellular_sulfatase_C | 4.66e-05 | 2 | 128 | 2 | IPR024609 | |
| Domain | DUF3740 | 4.66e-05 | 2 | 128 | 2 | PF12548 | |
| Domain | OSTEONECTIN_1 | 4.66e-05 | 2 | 128 | 2 | PS00612 | |
| Domain | OSTEONECTIN_2 | 4.66e-05 | 2 | 128 | 2 | PS00613 | |
| Domain | FOLN | 4.60e-04 | 5 | 128 | 2 | PF09289 | |
| Domain | Follistatin/Osteonectin_EGF | 4.60e-04 | 5 | 128 | 2 | IPR015369 | |
| Domain | Hematopoietin_rcpt_Gp130_CS | 9.57e-04 | 7 | 128 | 2 | IPR003529 | |
| Domain | SPARC/Testican_Ca-bd-dom | 1.27e-03 | 8 | 128 | 2 | IPR019577 | |
| Domain | HEMATOPO_REC_L_F2 | 1.27e-03 | 8 | 128 | 2 | PS01353 | |
| Domain | SPARC_Ca_bdg | 1.27e-03 | 8 | 128 | 2 | PF10591 | |
| Domain | - | 2.11e-03 | 333 | 128 | 8 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 2.19e-03 | 335 | 128 | 8 | IPR015943 | |
| Domain | Fol_N | 2.46e-03 | 11 | 128 | 2 | IPR003645 | |
| Domain | Spy1 | 2.46e-03 | 11 | 128 | 2 | PF11357 | |
| Domain | MBOAT | 2.46e-03 | 11 | 128 | 2 | PF03062 | |
| Domain | MBOAT_fam | 2.46e-03 | 11 | 128 | 2 | IPR004299 | |
| Domain | Speedy | 2.46e-03 | 11 | 128 | 2 | IPR020984 | |
| Domain | FOLN | 2.46e-03 | 11 | 128 | 2 | SM00274 | |
| Domain | Quinoprot_gluc/sorb_DH | 2.94e-03 | 12 | 128 | 2 | IPR011041 | |
| Domain | APOBEC_N | 2.94e-03 | 12 | 128 | 2 | PF08210 | |
| Domain | APOBEC_N | 2.94e-03 | 12 | 128 | 2 | IPR013158 | |
| Domain | WD_REPEATS_1 | 3.07e-03 | 278 | 128 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 3.14e-03 | 279 | 128 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.14e-03 | 279 | 128 | 7 | PS50294 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 4.02e-03 | 14 | 128 | 2 | IPR016192 | |
| Domain | CNH | 4.02e-03 | 14 | 128 | 2 | SM00036 | |
| Domain | CNH | 4.62e-03 | 15 | 128 | 2 | PF00780 | |
| Domain | CNH | 4.62e-03 | 15 | 128 | 2 | PS50219 | |
| Domain | CNH_dom | 4.62e-03 | 15 | 128 | 2 | IPR001180 | |
| Domain | Chemokine_rcpt | 5.25e-03 | 16 | 128 | 2 | IPR000355 | |
| Domain | Sulfatase_CS | 5.25e-03 | 16 | 128 | 2 | IPR024607 | |
| Domain | p53-like_TF_DNA-bd | 5.74e-03 | 53 | 128 | 3 | IPR008967 | |
| Domain | TF_T-box | 5.93e-03 | 17 | 128 | 2 | IPR001699 | |
| Domain | SULFATASE_1 | 5.93e-03 | 17 | 128 | 2 | PS00523 | |
| Domain | CarboxyPept-like_regulatory | 5.93e-03 | 17 | 128 | 2 | IPR008969 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 5.93e-03 | 17 | 128 | 2 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 5.93e-03 | 17 | 128 | 2 | IPR002125 | |
| Domain | TBOX | 5.93e-03 | 17 | 128 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 5.93e-03 | 17 | 128 | 2 | IPR018186 | |
| Domain | - | 5.93e-03 | 17 | 128 | 2 | 2.60.40.820 | |
| Domain | Cytidine_deaminase-like | 5.93e-03 | 17 | 128 | 2 | IPR016193 | |
| Domain | TBOX_3 | 5.93e-03 | 17 | 128 | 2 | PS50252 | |
| Domain | T-box | 5.93e-03 | 17 | 128 | 2 | PF00907 | |
| Domain | SULFATASE_2 | 5.93e-03 | 17 | 128 | 2 | PS00149 | |
| Domain | TBOX_1 | 5.93e-03 | 17 | 128 | 2 | PS01283 | |
| Domain | TBOX_2 | 5.93e-03 | 17 | 128 | 2 | PS01264 | |
| Domain | Sulfatase | 6.64e-03 | 18 | 128 | 2 | PF00884 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 6.64e-03 | 18 | 128 | 2 | PS00754 | |
| Domain | Sulfatase_N | 6.64e-03 | 18 | 128 | 2 | IPR000917 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 1.33e-11 | 28 | 100 | 8 | M47898 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.34e-11 | 17 | 100 | 7 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.18e-11 | 18 | 100 | 7 | M47753 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | TUBA3D TUBA1C LRRC49 TPGS2 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 2.79e-11 | 46 | 100 | 9 | M27828 |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.43e-11 | 19 | 100 | 7 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.43e-11 | 19 | 100 | 7 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 5.25e-11 | 20 | 100 | 7 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 5.25e-11 | 20 | 100 | 7 | M47911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 5.79e-11 | 33 | 100 | 8 | M47901 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 7.83e-11 | 21 | 100 | 7 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 7.83e-11 | 21 | 100 | 7 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.14e-10 | 22 | 100 | 7 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 1.63e-10 | 23 | 100 | 7 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 1.63e-10 | 23 | 100 | 7 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 1.63e-10 | 23 | 100 | 7 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 2.29e-10 | 24 | 100 | 7 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.29e-10 | 24 | 100 | 7 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 3.16e-10 | 25 | 100 | 7 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.16e-10 | 25 | 100 | 7 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 4.30e-10 | 26 | 100 | 7 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 4.30e-10 | 26 | 100 | 7 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 5.70e-10 | 43 | 100 | 8 | M47773 | |
| Pathway | REACTOME_AGGREPHAGY | 6.93e-10 | 44 | 100 | 8 | M29830 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 1.00e-09 | 29 | 100 | 7 | M27948 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.27e-09 | 17 | 100 | 6 | MM14731 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 2.13e-09 | 32 | 100 | 7 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.13e-09 | 32 | 100 | 7 | M27491 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 2.68e-09 | 33 | 100 | 7 | M27297 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.29e-09 | 53 | 100 | 8 | M27651 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 4.18e-09 | 35 | 100 | 7 | M47774 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 4.46e-09 | 55 | 100 | 8 | M39613 | |
| Pathway | REACTOME_AGGREPHAGY | 5.15e-09 | 36 | 100 | 7 | MM15669 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 5.18e-09 | 56 | 100 | 8 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 5.99e-09 | 57 | 100 | 8 | M27251 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 7.70e-09 | 38 | 100 | 7 | M14981 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.91e-08 | 43 | 100 | 7 | M47669 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | TUBA3D TUBA1C TUBA8 TUBGCP5 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1I2 | 2.24e-08 | 95 | 100 | 9 | M6729 |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.26e-08 | 44 | 100 | 7 | M27934 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 2.66e-08 | 45 | 100 | 7 | M47670 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 2.87e-08 | 27 | 100 | 6 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 2.87e-08 | 27 | 100 | 6 | MM15674 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 4.24e-08 | 48 | 100 | 7 | MM15353 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 4.56e-08 | 29 | 100 | 6 | MM15219 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 4.92e-08 | 49 | 100 | 7 | M891 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 6.12e-08 | 76 | 100 | 8 | M48037 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 6.55e-08 | 51 | 100 | 7 | M26972 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 7.53e-08 | 52 | 100 | 7 | MM14949 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 8.55e-08 | 32 | 100 | 6 | MM14730 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 2.13e-07 | 37 | 100 | 6 | MM15102 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 2.31e-07 | 20 | 100 | 5 | MM1383 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 2.32e-07 | 90 | 100 | 8 | M29841 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 2.32e-07 | 90 | 100 | 8 | MM14979 | |
| Pathway | REACTOME_KINESINS | 2.33e-07 | 61 | 100 | 7 | M977 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 4.04e-07 | 66 | 100 | 7 | MM17074 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | TUBA3D TUBA1C TUBA8 TUBA4A TUBA3C TUBA1B NBAS TUBA1A DYNC1I2 | 4.43e-07 | 134 | 100 | 9 | M27751 |
| Pathway | REACTOME_PROTEIN_FOLDING | 4.49e-07 | 98 | 100 | 8 | M776 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.97e-07 | 68 | 100 | 7 | MM14968 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 5.25e-07 | 100 | 100 | 8 | M27650 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 6.12e-07 | 102 | 100 | 8 | M27648 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 6.22e-07 | 44 | 100 | 6 | MM14606 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 6.71e-07 | 71 | 100 | 7 | M39690 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 7.39e-07 | 72 | 100 | 7 | M26954 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 8.12e-07 | 73 | 100 | 7 | MM15672 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.07e-06 | 76 | 100 | 7 | M27215 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.40e-06 | 79 | 100 | 7 | M27743 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 2.15e-06 | 54 | 100 | 6 | M27482 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.25e-06 | 121 | 100 | 8 | M872 | |
| Pathway | REACTOME_KINESINS | 2.97e-06 | 57 | 100 | 6 | MM15714 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 3.05e-06 | 126 | 100 | 8 | M705 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 3.23e-06 | 127 | 100 | 8 | M27181 | |
| Pathway | KEGG_GAP_JUNCTION | 3.38e-06 | 90 | 100 | 7 | M4013 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 4.08e-06 | 131 | 100 | 8 | MM15497 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 4.52e-06 | 94 | 100 | 7 | M2843 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 4.52e-06 | 94 | 100 | 7 | MM14515 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 5.97e-06 | 98 | 100 | 7 | MM15352 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 6.00e-06 | 138 | 100 | 8 | M29805 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 6.68e-06 | 140 | 100 | 8 | M27550 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 8.40e-06 | 68 | 100 | 6 | MM14921 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.16e-05 | 151 | 100 | 8 | M550 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | TUBA3D TUBA1C TUBA8 TUBGCP5 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1I2 | 1.21e-05 | 200 | 100 | 9 | M864 |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.27e-05 | 73 | 100 | 6 | MM15491 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.28e-05 | 110 | 100 | 7 | MM15350 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | TUBA3D TUBA1C TUBA8 TUBA4A TUBA3C TUBA1B NBAS TUBA1A DYNC1I2 | 1.37e-05 | 203 | 100 | 9 | M27654 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | TUBA3D TUBA1C TUBA8 TUBGCP5 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1I2 | 1.42e-05 | 204 | 100 | 9 | M4217 |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.48e-05 | 156 | 100 | 8 | M27097 | |
| Pathway | REACTOME_AUTOPHAGY | 1.62e-05 | 158 | 100 | 8 | M27935 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.81e-05 | 116 | 100 | 7 | MM14855 | |
| Pathway | REACTOME_HCMV_INFECTION | 1.94e-05 | 162 | 100 | 8 | M29804 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 3.24e-05 | 52 | 100 | 5 | MM15211 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 3.61e-05 | 129 | 100 | 7 | MM14894 | |
| Pathway | REACTOME_MACROAUTOPHAGY | 3.79e-05 | 130 | 100 | 7 | MM14627 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 4.84e-05 | 184 | 100 | 8 | MM15145 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 5.43e-05 | 187 | 100 | 8 | M961 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 5.55e-05 | 138 | 100 | 7 | MM15635 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 5.85e-05 | 189 | 100 | 8 | MM15356 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 6.30e-05 | 191 | 100 | 8 | M29614 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 6.36e-05 | 141 | 100 | 7 | MM15266 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 9.01e-05 | 201 | 100 | 8 | M27472 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 9.33e-05 | 202 | 100 | 8 | MM15362 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 9.40e-05 | 150 | 100 | 7 | M27440 | |
| Pubmed | 3.45e-16 | 9 | 132 | 7 | 21167302 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 7.42e-14 | 8 | 132 | 6 | 16148047 | |
| Pubmed | 4.69e-13 | 19 | 132 | 7 | 15698476 | ||
| Pubmed | 4.69e-13 | 19 | 132 | 7 | 15691386 | ||
| Pubmed | 1.57e-12 | 22 | 132 | 7 | 28117675 | ||
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 2.42e-12 | 12 | 132 | 6 | 15331610 | |
| Pubmed | 4.36e-12 | 6 | 132 | 5 | 3785200 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 4.36e-12 | 6 | 132 | 5 | 7651436 | |
| Pubmed | 4.36e-12 | 6 | 132 | 5 | 16327313 | ||
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 4.47e-12 | 13 | 132 | 6 | 10908577 | |
| Pubmed | 7.81e-12 | 14 | 132 | 6 | 12486001 | ||
| Pubmed | 1.52e-11 | 7 | 132 | 5 | 11146551 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 9.08e-11 | 9 | 132 | 5 | 11953448 | |
| Pubmed | 1.89e-10 | 22 | 132 | 6 | 15103018 | ||
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 1.89e-10 | 22 | 132 | 6 | 23826228 | |
| Pubmed | 1.98e-10 | 4 | 132 | 4 | 18400243 | ||
| Pubmed | 4.35e-09 | 17 | 132 | 5 | 17360745 | ||
| Pubmed | 6.88e-09 | 7 | 132 | 4 | 36681692 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 11163133 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 5.34e-08 | 3 | 132 | 3 | 9722999 | |
| Pubmed | EPRS1 HSDL2 TUBA1C ITGAV LEPR SEMA4C TUBA1B LIFR POGLUT1 COCH TUBA1A FDFT1 DDX3Y PRKDC | 9.80e-08 | 613 | 132 | 14 | 22268729 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.02e-06 | 271 | 132 | 9 | 32433965 | |
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 18613978 | ||
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 12090300 | ||
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 10840040 | ||
| Pubmed | 1.61e-06 | 212 | 132 | 8 | 23463506 | ||
| Pubmed | 1.66e-06 | 23 | 132 | 4 | 34473953 | ||
| Pubmed | Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C. | 1.85e-06 | 7 | 132 | 3 | 20921899 | |
| Pubmed | 2.95e-06 | 8 | 132 | 3 | 14583623 | ||
| Pubmed | 2.98e-06 | 104 | 132 | 6 | 36055981 | ||
| Pubmed | 4.41e-06 | 9 | 132 | 3 | 19103752 | ||
| Pubmed | EPRS1 TUBA1C CDS2 TUBA4A TUBA3C CKB TUBA1B BPNT2 TUBA1A PRMT1 DDX3Y PRKDC LRBA DYNC1I2 | 6.72e-06 | 878 | 132 | 14 | 37223481 | |
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 8.62e-06 | 11 | 132 | 3 | 20405035 | |
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 8.64e-06 | 125 | 132 | 6 | 36030824 | |
| Pubmed | 1.09e-05 | 76 | 132 | 5 | 27542412 | ||
| Pubmed | 1.19e-05 | 37 | 132 | 4 | 26951610 | ||
| Pubmed | Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity. | 1.43e-05 | 2 | 132 | 2 | 16901266 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 33920782 | ||
| Pubmed | HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. | 1.43e-05 | 2 | 132 | 2 | 16192265 | |
| Pubmed | Epithelial Deletion of Sulf2 Exacerbates Bleomycin-Induced Lung Injury, Inflammation, and Mortality. | 1.43e-05 | 2 | 132 | 2 | 28657777 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22532369 | ||
| Pubmed | SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression. | 1.43e-05 | 2 | 132 | 2 | 24726914 | |
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 1.43e-05 | 2 | 132 | 2 | 24268707 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 20394677 | ||
| Pubmed | SULFs in human neoplasia: implication as progression and prognosis factors. | 1.43e-05 | 2 | 132 | 2 | 21599997 | |
| Pubmed | Altered Anterior Segment Biometric Parameters in Mice Deficient in SPARC. | 1.43e-05 | 2 | 132 | 2 | 28122087 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27294358 | ||
| Pubmed | Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways. | 1.43e-05 | 2 | 132 | 2 | 20479257 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15743803 | ||
| Pubmed | Cloning and expression of murine SC1, a gene product homologous to SPARC. | 1.43e-05 | 2 | 132 | 2 | 9199668 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26448642 | ||
| Pubmed | Interplay between hevin, SPARC, and MDGAs: Modulators of neurexin-neuroligin transsynaptic bridges. | 1.43e-05 | 2 | 132 | 2 | 33535026 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 35131262 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25328666 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 34489650 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12054644 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17920055 | ||
| Pubmed | Structural features and restricted expression of a human alpha-tubulin gene. | 1.43e-05 | 2 | 132 | 2 | 3839072 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12368295 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 33493647 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23418199 | ||
| Pubmed | The exon structure of the mouse Sc1 gene is very similar to the mouse Sparc gene. | 1.43e-05 | 2 | 132 | 2 | 8938431 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 34324645 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 18687675 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 31461325 | ||
| Pubmed | Functional consequences of the subdomain organization of the sulfs. | 1.43e-05 | 2 | 132 | 2 | 19520866 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23950901 | ||
| Pubmed | Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection. | 1.43e-05 | 2 | 132 | 2 | 23480519 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 18507859 | ||
| Pubmed | Modulation of SPARC/Hevin Proteins in Alzheimer's Disease Brain Injury. | 1.43e-05 | 2 | 132 | 2 | 30883351 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26764203 | ||
| Pubmed | SULF1/SULF2 reactivation during liver damage and tumour growth. | 1.43e-05 | 2 | 132 | 2 | 27013228 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 31434553 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 29360432 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 14578206 | ||
| Pubmed | Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. | 1.43e-05 | 2 | 132 | 2 | 21788491 | |
| Pubmed | Automated, computerized, feature-based phenotype analysis of slit lamp images of the mouse lens. | 1.43e-05 | 2 | 132 | 2 | 18304532 | |
| Pubmed | Enhanced tumorigenic potential of colorectal cancer cells by extracellular sulfatases. | 1.43e-05 | 2 | 132 | 2 | 25477293 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22298771 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22296162 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 32038163 | ||
| Pubmed | 1.49e-05 | 13 | 132 | 3 | 14697242 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 1.52e-05 | 288 | 132 | 8 | 31501420 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | TNIK TTC39B PLBD1 SPARC CDS2 CPT2 LRRC8D SMYD2 BPNT2 FDFT1 PRMT1 IL23R ADGRD1 DYNC1I2 SDHC PUS7L | 2.05e-05 | 1242 | 132 | 16 | 30973865 |
| Pubmed | Channel-interacting PDZ protein, 'CIPP', interacts with proteins involved in cytoskeletal dynamics. | 2.89e-05 | 16 | 132 | 3 | 19138174 | |
| Pubmed | Asprosin-neutralizing antibodies as a treatment for metabolic syndrome. | 2.89e-05 | 16 | 132 | 3 | 33904407 | |
| Pubmed | 3.04e-05 | 156 | 132 | 6 | 37108203 | ||
| Pubmed | 3.06e-05 | 94 | 132 | 5 | 36584595 | ||
| Pubmed | CDS2 NCK1 TTC3 TUBGCP5 LRRC8D TUBA4A SLC5A3 CKB LIFR POGLUT1 BTD KLHL13 GNPDA2 RECQL5 CMKLR1 DYNC1I2 | 3.33e-05 | 1293 | 132 | 16 | 15342556 | |
| Pubmed | EPRS1 TUBA1C TUBA8 TUBA4A CKB TUBA1B TUBA1A FDFT1 MRPS33 PRMT1 DDX3Y PRKDC FBXO21 ADGRD1 DYNC1I2 | 3.38e-05 | 1153 | 132 | 15 | 29845934 | |
| Pubmed | 3.39e-05 | 48 | 132 | 4 | 33504946 | ||
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 3.74e-05 | 98 | 132 | 5 | 21942715 | |
| Pubmed | 3.77e-05 | 239 | 132 | 7 | 23246001 | ||
| Pubmed | 3.99e-05 | 50 | 132 | 4 | 23703321 | ||
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 4.28e-05 | 3 | 132 | 2 | 27602762 | |
| Pubmed | Identification of alpha-tubulin as an hsp105alpha-binding protein by the yeast two-hybrid system. | 4.28e-05 | 3 | 132 | 2 | 12749852 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 22691411 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 4.28e-05 | 3 | 132 | 2 | 22666481 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 31767681 | ||
| Interaction | TCP11L2 interactions | 2.93e-09 | 21 | 128 | 6 | int:TCP11L2 | |
| Interaction | GRM7 interactions | 1.03e-07 | 19 | 128 | 5 | int:GRM7 | |
| Interaction | FBXO6 interactions | B3GALNT1 EPRS1 HSDL2 TUBA1C ITGAV LEPR SEMA4C TUBA1B LIFR POGLUT1 SULF2 COCH TENM4 TUBA1A FDFT1 BTD DDX3Y PRKDC | 6.57e-07 | 717 | 128 | 18 | int:FBXO6 |
| Interaction | IGHD interactions | 8.35e-07 | 28 | 128 | 5 | int:IGHD | |
| Interaction | INSL5 interactions | 1.80e-06 | 58 | 128 | 6 | int:INSL5 | |
| Interaction | BAGE2 interactions | 5.49e-06 | 70 | 128 | 6 | int:BAGE2 | |
| Interaction | TRAV20 interactions | 1.31e-05 | 48 | 128 | 5 | int:TRAV20 | |
| Interaction | TXNDC9 interactions | 1.44e-05 | 124 | 128 | 7 | int:TXNDC9 | |
| Interaction | MIR106A interactions | 1.48e-05 | 83 | 128 | 6 | int:MIR106A | |
| Interaction | RAMP3 interactions | 1.69e-05 | 176 | 128 | 8 | int:RAMP3 | |
| Interaction | LTA interactions | 2.82e-05 | 28 | 128 | 4 | int:LTA | |
| Interaction | MIRLET7D interactions | 4.52e-05 | 101 | 128 | 6 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 4.52e-05 | 101 | 128 | 6 | int:MIR25 | |
| Interaction | MIR15B interactions | 5.04e-05 | 103 | 128 | 6 | int:MIR15B | |
| Interaction | MIR7-1 interactions | 5.04e-05 | 103 | 128 | 6 | int:MIR7-1 | |
| Interaction | MIR34A interactions | 5.32e-05 | 104 | 128 | 6 | int:MIR34A | |
| Interaction | KLK11 interactions | 7.81e-05 | 36 | 128 | 4 | int:KLK11 | |
| Interaction | SCGB2A2 interactions | 9.08e-05 | 223 | 128 | 8 | int:SCGB2A2 | |
| Interaction | INSYN2A interactions | 1.07e-04 | 39 | 128 | 4 | int:INSYN2A | |
| Interaction | TRAC interactions | 1.08e-04 | 15 | 128 | 3 | int:TRAC | |
| Interaction | CAPSL interactions | 1.08e-04 | 15 | 128 | 3 | int:CAPSL | |
| Interaction | MIR20A interactions | 1.08e-04 | 74 | 128 | 5 | int:MIR20A | |
| Interaction | CEACAM8 interactions | 1.13e-04 | 119 | 128 | 6 | int:CEACAM8 | |
| Interaction | DCAF12L1 interactions | 1.20e-04 | 3 | 128 | 2 | int:DCAF12L1 | |
| Interaction | MIR199A2 interactions | 1.23e-04 | 76 | 128 | 5 | int:MIR199A2 | |
| Interaction | TMEM72 interactions | 1.31e-04 | 41 | 128 | 4 | int:TMEM72 | |
| Interaction | MIR451A interactions | 1.39e-04 | 78 | 128 | 5 | int:MIR451A | |
| Interaction | CCL3 interactions | 1.44e-04 | 178 | 128 | 7 | int:CCL3 | |
| Interaction | AQP3 interactions | 1.47e-04 | 239 | 128 | 8 | int:AQP3 | |
| Interaction | MIR222 interactions | 1.48e-04 | 79 | 128 | 5 | int:MIR222 | |
| Interaction | GPR182 interactions | CDS2 PTDSS2 TUBGCP5 TUBA3C SLC5A3 TUBA1A FDFT1 LPCAT3 UTP20 PRKDC SEC14L1 | 1.57e-04 | 455 | 128 | 11 | int:GPR182 |
| Interaction | ATOH1 interactions | 1.57e-04 | 80 | 128 | 5 | int:ATOH1 | |
| Interaction | MIR143 interactions | 1.57e-04 | 80 | 128 | 5 | int:MIR143 | |
| Interaction | MIR145 interactions | 1.66e-04 | 81 | 128 | 5 | int:MIR145 | |
| Interaction | MIR200B interactions | 1.97e-04 | 84 | 128 | 5 | int:MIR200B | |
| Interaction | MIR31 interactions | 1.97e-04 | 84 | 128 | 5 | int:MIR31 | |
| Interaction | MIR7-2 interactions | 1.97e-04 | 84 | 128 | 5 | int:MIR7-2 | |
| Interaction | PRSS50 interactions | 2.06e-04 | 46 | 128 | 4 | int:PRSS50 | |
| Interaction | MIR107 interactions | 2.09e-04 | 85 | 128 | 5 | int:MIR107 | |
| Interaction | MIR18B interactions | 2.09e-04 | 85 | 128 | 5 | int:MIR18B | |
| Interaction | LYZL2 interactions | 2.09e-04 | 85 | 128 | 5 | int:LYZL2 | |
| Interaction | B3GNT3 interactions | 2.09e-04 | 85 | 128 | 5 | int:B3GNT3 | |
| Interaction | TMEM25 interactions | 2.16e-04 | 134 | 128 | 6 | int:TMEM25 | |
| Interaction | MIR20B interactions | 2.21e-04 | 86 | 128 | 5 | int:MIR20B | |
| Interaction | MIR29A interactions | 2.33e-04 | 87 | 128 | 5 | int:MIR29A | |
| Interaction | GNS interactions | 2.34e-04 | 136 | 128 | 6 | int:GNS | |
| Interaction | TCP1 interactions | EPRS1 PLBD1 TUBA1C JMJD4 TUBA8 TUBA4A APOBEC3B TUBA1B TUBA1A FBXW5 PRMT1 DYNC1I2 | 2.44e-04 | 561 | 128 | 12 | int:TCP1 |
| Interaction | MIR221 interactions | 2.73e-04 | 90 | 128 | 5 | int:MIR221 | |
| Interaction | MIR92A2 interactions | 2.73e-04 | 90 | 128 | 5 | int:MIR92A2 | |
| Interaction | MIR1-1 interactions | 2.73e-04 | 90 | 128 | 5 | int:MIR1-1 | |
| Interaction | PRTN3 interactions | 2.87e-04 | 91 | 128 | 5 | int:PRTN3 | |
| Interaction | FBXO2 interactions | 2.98e-04 | 411 | 128 | 10 | int:FBXO2 | |
| Interaction | GPR173 interactions | 3.08e-04 | 51 | 128 | 4 | int:GPR173 | |
| Interaction | MIR19B2 interactions | 3.34e-04 | 94 | 128 | 5 | int:MIR19B2 | |
| Interaction | MIRLET7F1 interactions | 3.34e-04 | 94 | 128 | 5 | int:MIRLET7F1 | |
| Interaction | HCST interactions | 3.40e-04 | 205 | 128 | 7 | int:HCST | |
| Interaction | VIPR1 interactions | 3.40e-04 | 205 | 128 | 7 | int:VIPR1 | |
| Interaction | D2HGDH interactions | 3.43e-04 | 146 | 128 | 6 | int:D2HGDH | |
| Interaction | CCT6B interactions | 3.61e-04 | 207 | 128 | 7 | int:CCT6B | |
| Interaction | MIRLET7A2 interactions | 3.68e-04 | 96 | 128 | 5 | int:MIRLET7A2 | |
| Interaction | MIR363 interactions | 3.86e-04 | 97 | 128 | 5 | int:MIR363 | |
| Interaction | MIR106B interactions | 4.05e-04 | 98 | 128 | 5 | int:MIR106B | |
| Interaction | MIR128-2 interactions | 4.24e-04 | 99 | 128 | 5 | int:MIR128-2 | |
| Interaction | GABRA1 interactions | 4.25e-04 | 152 | 128 | 6 | int:GABRA1 | |
| Interaction | GPR17 interactions | 4.58e-04 | 283 | 128 | 8 | int:GPR17 | |
| Interaction | LY86 interactions | 4.79e-04 | 217 | 128 | 7 | int:LY86 | |
| Interaction | OPRL1 interactions | 4.87e-04 | 102 | 128 | 5 | int:OPRL1 | |
| Interaction | MIRLET7A3 interactions | 4.87e-04 | 102 | 128 | 5 | int:MIRLET7A3 | |
| Interaction | NAAA interactions | 5.20e-04 | 220 | 128 | 7 | int:NAAA | |
| Interaction | CAPS interactions | 5.20e-04 | 25 | 128 | 3 | int:CAPS | |
| Interaction | BRINP3 interactions | 5.20e-04 | 25 | 128 | 3 | int:BRINP3 | |
| Interaction | DHFR2 interactions | 5.26e-04 | 289 | 128 | 8 | int:DHFR2 | |
| Interaction | MIR19B1 interactions | 5.32e-04 | 104 | 128 | 5 | int:MIR19B1 | |
| Interaction | CSGALNACT2 interactions | 5.80e-04 | 106 | 128 | 5 | int:CSGALNACT2 | |
| Interaction | MIRLET7E interactions | 5.80e-04 | 106 | 128 | 5 | int:MIRLET7E | |
| Cytoband | 12q13.12 | 1.82e-04 | 38 | 132 | 3 | 12q13.12 | |
| GeneFamily | Tubulins | 3.64e-11 | 26 | 90 | 7 | 778 | |
| GeneFamily | Membrane bound O-acyltransferases | 5.06e-04 | 7 | 90 | 2 | 1036 | |
| GeneFamily | SPARC family | 6.73e-04 | 8 | 90 | 2 | 1278 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 1.57e-03 | 12 | 90 | 2 | 406 | |
| GeneFamily | WD repeat domain containing | 1.97e-03 | 262 | 90 | 6 | 362 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 2.09e-03 | 51 | 90 | 3 | 870 | |
| GeneFamily | Sulfatases | 3.56e-03 | 18 | 90 | 2 | 410 | |
| GeneFamily | T-boxes | 3.56e-03 | 18 | 90 | 2 | 766 | |
| Coexpression | RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN | EPRS1 SPARC NSD2 TUBA1C TPGS2 SLC5A3 TUBA1B TUBA1A MRPS33 PRMT1 SLC35E3 PRKDC SDHC | 3.98e-08 | 368 | 130 | 13 | M1859 |
| Coexpression | GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP | 7.27e-07 | 200 | 130 | 9 | M3038 | |
| Coexpression | ALONSO_METASTASIS_EMT_UP | 8.00e-07 | 35 | 130 | 5 | M8191 | |
| Coexpression | GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP | 7.32e-06 | 200 | 130 | 8 | M3035 | |
| Coexpression | WANG_CLIM2_TARGETS_UP | 8.50e-06 | 270 | 130 | 9 | M10334 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN | 6.29e-05 | 199 | 130 | 7 | M6660 | |
| Coexpression | GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP | 6.29e-05 | 199 | 130 | 7 | M4316 | |
| Coexpression | GSE2826_WT_VS_XID_BCELL_UP | 6.49e-05 | 200 | 130 | 7 | M4895 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP | 6.49e-05 | 200 | 130 | 7 | M3780 | |
| Coexpression | GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN | 6.49e-05 | 200 | 130 | 7 | M8504 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN | 6.49e-05 | 200 | 130 | 7 | M4358 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-07 | 129 | 132 | 7 | 2f30b4897343586c9b49a1d2bec3007ec737085c | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 1.36e-06 | 185 | 132 | 7 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.41e-06 | 186 | 132 | 7 | c9dfcf7bba7e5ef97ad5d9b7084fba932c91ab68 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.68e-06 | 191 | 132 | 7 | be2fe2583bdcee0b35c43a347da9c4adb93e30e0 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.68e-06 | 191 | 132 | 7 | 4cebaf31d4f09f4ab273a819ad5cbff7d9a9b341 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 1.74e-06 | 192 | 132 | 7 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.13e-06 | 198 | 132 | 7 | a7eed9eeb728a8796e2780090cc244856efd8c65 | |
| ToppCell | distal-Endothelial-Capillary-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.20e-06 | 199 | 132 | 7 | d27fbd9a651821b2859dfa80bce4e6fc6f8299fc | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_capillary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-06 | 199 | 132 | 7 | 772b3f60b83e29b958e1e70dadfd9f058ed4cb7c | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-06 | 200 | 132 | 7 | ec9a18576a3d08ddfceb70d114c4ab861fbb0d08 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.28e-06 | 200 | 132 | 7 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.69e-06 | 154 | 132 | 6 | a90c4c45685eae8d21d03479cfd5a23f6ed3ca07 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.21e-06 | 156 | 132 | 6 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.21e-06 | 156 | 132 | 6 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.33e-06 | 160 | 132 | 6 | 8590281165eab6514a9f6a022b900d4c222c1044 | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 1.26e-05 | 172 | 132 | 6 | 0657c736f3c52d25cf7f652eac005ddcde9232ef | |
| ToppCell | droplet-Limb_Muscle-nan-24m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 172 | 132 | 6 | 770e4c5467ef2eaddf883723fb0aa1226973b000 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 173 | 132 | 6 | 506efcaa5afd6ed5e565c4c4def6a4505fea97c5 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-05 | 183 | 132 | 6 | 269afec240a756eec3bbae5f30ec784281af3433 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-05 | 184 | 132 | 6 | 5cfc19ffb9f074bdf0d81c86e212a708ec141631 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-osteoclast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.90e-05 | 185 | 132 | 6 | 5ed49b6d8214c6119355a6d3ee4e25d40bcc0c53 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.96e-05 | 186 | 132 | 6 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.02e-05 | 187 | 132 | 6 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-osteoclast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.08e-05 | 188 | 132 | 6 | 762b52f21d2bc5409f86746a904c4358490be9c0 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 189 | 132 | 6 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 189 | 132 | 6 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 189 | 132 | 6 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 2.21e-05 | 190 | 132 | 6 | ec0ab31266583a0966ac7615d5c0fabb7b7e66e8 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 190 | 132 | 6 | 84265be128170cbb08d76e824aa108e07da9c3e5 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.41e-05 | 193 | 132 | 6 | e477f5ddbb9d5878560998250ca0e1a5467953f4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 193 | 132 | 6 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | ASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.55e-05 | 195 | 132 | 6 | 304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56 | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|World / Lineage and Cell class | 2.55e-05 | 195 | 132 | 6 | 69723b06c2a5c2aaf4d10874b11bca7f06822bdc | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|(2)_5-FU / Stress and Cell class | 2.63e-05 | 196 | 132 | 6 | cc0a172de71d9a1a882c9e78652dae70e007d012 | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 2.70e-05 | 197 | 132 | 6 | 434ae0231972acba12d06279908cf407e70511ac | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 197 | 132 | 6 | 6806ec223e542f0475303698eb78c1cc527f5c6b | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.70e-05 | 197 | 132 | 6 | 1bf69db7e830315c8fa85e6e85b0cb94014e9169 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 198 | 132 | 6 | d4f74320ea6c1a7e568ee5bc48bb66cb45e1004d | |
| ToppCell | 343B-Endothelial_cells|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-05 | 198 | 132 | 6 | fab32347580c7a81ef1fe4fe7b325d9105a947d9 | |
| ToppCell | distal-Endothelial-Artery-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.78e-05 | 198 | 132 | 6 | f284f59f4ebe55ee132eddfaa2f5d9ecb059654f | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-05 | 198 | 132 | 6 | 2400f8b8c51739ea2ae2b9f24f44eaeefa2bb6fc | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 198 | 132 | 6 | 002424b24dacac553e02d0f764a6e8a1e567b9df | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Capillary|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.86e-05 | 199 | 132 | 6 | 3fea92affacd4c1f588fa81807df35d6c69b7241 | |
| ToppCell | normal_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.86e-05 | 199 | 132 | 6 | 72c96a5954dfcfbfee8f095984ce1f5249d9a679 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Capillary-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.86e-05 | 199 | 132 | 6 | 993999adf346b4fd557989bc53c17eb0ccb996c9 | |
| ToppCell | distal-1-Endothelial-Capillary|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.86e-05 | 199 | 132 | 6 | 4b22769882fdd83f9cdca59e4d39ef441e62856b | |
| ToppCell | distal-Endothelial-Artery|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.86e-05 | 199 | 132 | 6 | b6e9aaac047d4b64b9d97f5e174e89a424d8b36d | |
| ToppCell | medial-Endothelial-Artery|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.86e-05 | 199 | 132 | 6 | 341c0be18bec66f4cc8bda232dce54edb34b9cda | |
| ToppCell | tumor_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.86e-05 | 199 | 132 | 6 | 80c8641cfd84436eadf2234f1313749e2f73331f | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-05 | 199 | 132 | 6 | 6cfe5a3d0ad530411ebc11decb4ab4c529e018d5 | |
| ToppCell | medial-2-Endothelial-Artery|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.86e-05 | 199 | 132 | 6 | 53c17c0493f82351a039bc64def191311e0f4951 | |
| ToppCell | medial-Endothelial-Artery-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.86e-05 | 199 | 132 | 6 | c455f5a2802f2ec6f0e24266de1aaf3203ca8c78 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Capillary|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.86e-05 | 199 | 132 | 6 | 89f4db619fbed90f7fdf6ece7a671e514b5c6d76 | |
| ToppCell | H1299-uninfected|H1299 / Cell line, Condition and Strain | 2.86e-05 | 199 | 132 | 6 | 4594eb3e6d29285155df8dfd322ccf532d7e94b8 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-05 | 199 | 132 | 6 | 8db1acdcabf97f01b9ca17456c48ec8ac4928390 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 200 | 132 | 6 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.94e-05 | 200 | 132 | 6 | 2ae62c428728c1d9d4471d4be24bd6ab074fa22c | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-05 | 200 | 132 | 6 | 24e43d3d16d07571f77e0cd5b2e4758c6ff802cb | |
| ToppCell | distal-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.94e-05 | 200 | 132 | 6 | 8daf09d63c2fda6da6e5b66f96e7449ee8b17029 | |
| ToppCell | medial-Endothelial|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.94e-05 | 200 | 132 | 6 | e889b593c2ae53c42944213ce8672cd886917105 | |
| ToppCell | distal-1-Endothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.94e-05 | 200 | 132 | 6 | 8f25b27c10e89cf9d0091bd53c24ce63ed7d6222 | |
| ToppCell | distal-Endothelial-Capillary|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.94e-05 | 200 | 132 | 6 | 0ee29b2bd9cd3a1c80e0535017814f752c3eb1fa | |
| ToppCell | medial-2-Endothelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.94e-05 | 200 | 132 | 6 | 70440db2d8be1e29aeb34ea5e8ac72641b5c056f | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.94e-05 | 200 | 132 | 6 | 13f6ac0dfc9206dd2e6cbd84357a5883952ee5c7 | |
| ToppCell | distal-Endothelial-Capillary-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.94e-05 | 200 | 132 | 6 | ab96d3d801373459a2503ccfb665dc3f43bfb5a1 | |
| ToppCell | ASK440-Endothelial-Endothelium|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.17e-05 | 122 | 132 | 5 | 2f76ec3b527e9528fbb006599a96e8bbdf9e0e62 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.59e-05 | 70 | 132 | 4 | 2121ba6a0beb2a8fdc589ff1063e7d8c2c3c68f6 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.59e-05 | 70 | 132 | 4 | cd6bca68fe52f451716fc8c0b1745984bc9ec057 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.59e-05 | 70 | 132 | 4 | be300c0447735aba89df4c3082b81eb5abf22770 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.21e-05 | 149 | 132 | 5 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 158 | 132 | 5 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 158 | 132 | 5 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 158 | 132 | 5 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-7|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.12e-04 | 159 | 132 | 5 | 70288df54adab167c0f50675128619299077db11 | |
| ToppCell | Mild-Lymphoid-Plasma|Mild / Condition, Lineage, Cell class and cell subclass | 1.15e-04 | 160 | 132 | 5 | 7fdb849f5caf5a127a2582326215e11f8eb4fa0e | |
| ToppCell | Mild-Lymphoid-Plasma-|Mild / Condition, Lineage, Cell class and cell subclass | 1.15e-04 | 160 | 132 | 5 | aa79848913910c01249d6cacf4ed53ec0e4f5c3d | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 166 | 132 | 5 | aa2df07eff323ded751ced8938af08223d7f2029 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 166 | 132 | 5 | 695298a94d62b8adab083900003ec636fbaae5d9 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-7|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.40e-04 | 167 | 132 | 5 | 01c42e555913b17e62846325cc17b3d8f92da1e1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 167 | 132 | 5 | 2184c2760b6142e62124a2454a552723e20d4f61 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 171 | 132 | 5 | 7ca404539344e14dcd90c746c9122f713a7db78b | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 171 | 132 | 5 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 171 | 132 | 5 | ab113c8e773b0af47a87aed50e96be3ba71c3c82 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 171 | 132 | 5 | 246fc7edcefc47437d1df6029f295aca3b34b2b2 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 171 | 132 | 5 | 1fb4e11f92b48dc2d6e553c22e2571bbd8c223c6 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|normal_Lung / Location, Cell class and cell subclass | 1.65e-04 | 173 | 132 | 5 | e8ead6c51c41dbd43c717ba9d1a7a0ab39c79330 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 173 | 132 | 5 | 3612772632ddf11eb48579cae9a8ccab6b3f1f52 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-04 | 173 | 132 | 5 | 7a3115e7cf7e2f345192cde0656a7f0193594a5f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-04 | 173 | 132 | 5 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 173 | 132 | 5 | 4dc261ebcdb9bdcfca1451da1bd254f0dc5de203 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-04 | 174 | 132 | 5 | 9d22a554617a93701d0945de63cc3e7b24322c40 | |
| ToppCell | Substantia_nigra-Macroglia|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.70e-04 | 174 | 132 | 5 | 7e7f7ca9a413ec255e54621800a279c771b9e6b7 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-04 | 174 | 132 | 5 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 1.75e-04 | 175 | 132 | 5 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-04 | 175 | 132 | 5 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 1.79e-04 | 176 | 132 | 5 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-04 | 177 | 132 | 5 | 84591e28482ab62a5ef41e61043eb64912766356 | |
| ToppCell | severe-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.84e-04 | 177 | 132 | 5 | d1ad35ee3d2a84b1d01126d0a38464ab858c00d0 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-04 | 177 | 132 | 5 | 4bc100062891d07cacd10ffba38966cc6302c92f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-04 | 177 | 132 | 5 | 9f3a2adb9cd4f0a059afc87b6e377a9702154bb1 | |
| Computational | Neighborhood of ERCC2 | 9.65e-05 | 104 | 77 | 6 | MORF_ERCC2 | |
| Drug | Epothilone D | 2.64e-11 | 12 | 129 | 6 | DB01873 | |
| Drug | Epothilone B | 2.64e-11 | 12 | 129 | 6 | DB03010 | |
| Drug | Cu-cyclam | 4.33e-09 | 43 | 129 | 7 | CID000467374 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 7.08e-07 | 4 | 129 | 3 | DB07574 | |
| Drug | B-Ms | 3.96e-06 | 114 | 129 | 7 | CID000445091 | |
| Drug | Stylophorin | 4.37e-06 | 43 | 129 | 5 | CID000010147 | |
| Drug | bromocolchicine | 5.46e-06 | 21 | 129 | 4 | CID000161518 | |
| Drug | colchifoline | 5.46e-06 | 21 | 129 | 4 | CID000100132 | |
| Drug | Ustiloxin A | 5.46e-06 | 21 | 129 | 4 | CID000164454 | |
| Drug | SRI-3072 | 5.46e-06 | 21 | 129 | 4 | CID000493469 | |
| Drug | LEO275 | 5.83e-06 | 79 | 129 | 6 | CID000018140 | |
| Drug | vinorelbine base | 6.28e-06 | 80 | 129 | 6 | CID000005672 | |
| Drug | 3,4,5-trimethoxyacetophenone | 6.65e-06 | 22 | 129 | 4 | CID000014345 | |
| Drug | AC1L1GIQ | 6.65e-06 | 22 | 129 | 4 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 6.65e-06 | 22 | 129 | 4 | CID000098538 | |
| Drug | SureCN13401588 | 6.65e-06 | 22 | 129 | 4 | CID009897422 | |
| Drug | N-methyldemecolcine | 6.65e-06 | 22 | 129 | 4 | CID000023759 | |
| Drug | NSC-339672 | 6.65e-06 | 22 | 129 | 4 | CID000433930 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 8.01e-06 | 23 | 129 | 4 | CID000006858 | |
| Drug | AC1L2P05 | 8.01e-06 | 23 | 129 | 4 | CID000125688 | |
| Drug | 2,3,4-tabp | 8.01e-06 | 23 | 129 | 4 | CID000125548 | |
| Drug | NSC-373301 | 8.01e-06 | 23 | 129 | 4 | CID000341375 | |
| Drug | NSC355636 | 8.01e-06 | 23 | 129 | 4 | CID000100176 | |
| Drug | IKP104 | 8.01e-06 | 23 | 129 | 4 | CID000130739 | |
| Drug | fluorescein-colchicine | 8.01e-06 | 23 | 129 | 4 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 8.01e-06 | 23 | 129 | 4 | CID000084076 | |
| Drug | 2,3,4-TCB | 8.01e-06 | 23 | 129 | 4 | CID000129239 | |
| Drug | N-acetylcolchinol | 8.01e-06 | 23 | 129 | 4 | CID000097865 | |
| Drug | parbendazole | 9.57e-06 | 24 | 129 | 4 | CID000026596 | |
| Drug | tropolone methyl ether | 9.57e-06 | 24 | 129 | 4 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 9.57e-06 | 24 | 129 | 4 | CID000330401 | |
| Drug | NABV | 9.57e-06 | 24 | 129 | 4 | CID000175959 | |
| Drug | AC1L4TG7 | 9.57e-06 | 24 | 129 | 4 | CID000163705 | |
| Drug | moscatilin | 9.57e-06 | 24 | 129 | 4 | CID000176096 | |
| Drug | NSC-36768 | 9.57e-06 | 24 | 129 | 4 | CID000165441 | |
| Drug | deacetamidocolchicine | 9.57e-06 | 24 | 129 | 4 | CID000014995 | |
| Drug | colchicide | 9.57e-06 | 24 | 129 | 4 | CID000120712 | |
| Drug | mpMap | 1.13e-05 | 25 | 129 | 4 | CID000100806 | |
| Drug | AC1Q6P06 | 1.13e-05 | 25 | 129 | 4 | CID000160263 | |
| Drug | allocolchicine | 1.13e-05 | 25 | 129 | 4 | CID000196989 | |
| Drug | 1069C85 | 1.13e-05 | 25 | 129 | 4 | CID006918099 | |
| Drug | 55623-37-5 | 1.13e-05 | 25 | 129 | 4 | CID006438440 | |
| Drug | MDL 27048 | 1.13e-05 | 25 | 129 | 4 | CID006439188 | |
| Drug | NBD-colcemid | 1.13e-05 | 25 | 129 | 4 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 1.13e-05 | 25 | 129 | 4 | CID000043264 | |
| Drug | CA1P | 1.13e-05 | 25 | 129 | 4 | CID006918545 | |
| Drug | peloruside A | 1.13e-05 | 25 | 129 | 4 | CID006918506 | |
| Drug | NSC142227 | 1.13e-05 | 25 | 129 | 4 | CID000073427 | |
| Drug | NSC527981 | 1.33e-05 | 26 | 129 | 4 | CID000352796 | |
| Drug | NSC332029 | 1.33e-05 | 26 | 129 | 4 | CID000100073 | |
| Drug | indibulin | 1.33e-05 | 26 | 129 | 4 | CID000002929 | |
| Drug | pironetin | 1.33e-05 | 26 | 129 | 4 | CID006438891 | |
| Drug | isaxonine | 1.33e-05 | 26 | 129 | 4 | CID000071169 | |
| Drug | NSC 89199 | 1.37e-05 | 54 | 129 | 5 | CID000003268 | |
| Drug | AC1L1J4H | 1.56e-05 | 27 | 129 | 4 | CID000004862 | |
| Drug | dinitroanilines | 1.56e-05 | 27 | 129 | 4 | CID000136400 | |
| Drug | NSC292222 | 1.56e-05 | 27 | 129 | 4 | CID000099957 | |
| Drug | NSC D-669356 | 1.56e-05 | 27 | 129 | 4 | CID000178028 | |
| Drug | 2,5-hexanedione | 1.64e-05 | 56 | 129 | 5 | CID000008035 | |
| Drug | NSC 370147 | 1.81e-05 | 28 | 129 | 4 | CID000182762 | |
| Drug | NSC72302 | 1.81e-05 | 28 | 129 | 4 | CID000118078 | |
| Drug | bp U | 2.09e-05 | 29 | 129 | 4 | CID000368697 | |
| Drug | oxibendazole | 2.09e-05 | 29 | 129 | 4 | CID000004622 | |
| Drug | Aids106696 | 2.09e-05 | 29 | 129 | 4 | CID006475933 | |
| Drug | ddGDP | 2.09e-05 | 29 | 129 | 4 | CID000134739 | |
| Drug | AC1NBBHE | 2.40e-05 | 30 | 129 | 4 | CID004490620 | |
| Drug | eleutherobin | 2.40e-05 | 30 | 129 | 4 | CID006918335 | |
| Drug | azatoxin | 2.40e-05 | 30 | 129 | 4 | CID000125383 | |
| Drug | NSC617668 | 2.40e-05 | 30 | 129 | 4 | CID000357989 | |
| Drug | citostal | 2.40e-05 | 30 | 129 | 4 | CID000018991 | |
| Drug | thiocolchicine | 2.40e-05 | 30 | 129 | 4 | CID000017648 | |
| Drug | NSC609395 | 2.75e-05 | 31 | 129 | 4 | CID005488798 | |
| Drug | amiprophosmethyl | 2.75e-05 | 31 | 129 | 4 | CID000100524 | |
| Drug | AC7700 | 2.75e-05 | 31 | 129 | 4 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 2.75e-05 | 31 | 129 | 4 | CID000032851 | |
| Drug | tropone | 2.75e-05 | 31 | 129 | 4 | CID000010881 | |
| Drug | AC1L3V8I | 2.75e-05 | 31 | 129 | 4 | CID000122777 | |
| Drug | NSC332598 | 2.75e-05 | 31 | 129 | 4 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 2.75e-05 | 31 | 129 | 4 | CID000023678 | |
| Drug | AC1L1G95 | 3.13e-05 | 32 | 129 | 4 | CID000003583 | |
| Drug | NSC153858 | 3.13e-05 | 32 | 129 | 4 | CID000547450 | |
| Drug | E2-3,4-Q | 3.13e-05 | 32 | 129 | 4 | CID000067402 | |
| Drug | 2-demethylcolchicine | 3.13e-05 | 32 | 129 | 4 | CID000023757 | |
| Drug | mebendazole | 3.54e-05 | 33 | 129 | 4 | CID000004030 | |
| Drug | CA4P | 3.54e-05 | 33 | 129 | 4 | CID000370232 | |
| Drug | taltobulin | 3.54e-05 | 33 | 129 | 4 | CID006918637 | |
| Drug | triethyllead | 4.00e-05 | 34 | 129 | 4 | CID006328106 | |
| Drug | NSC376450 | 4.00e-05 | 34 | 129 | 4 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 4.00e-05 | 34 | 129 | 4 | CID000161091 | |
| Drug | vindesine | 4.23e-05 | 68 | 129 | 5 | CID000040839 | |
| Drug | discodermolide | 4.49e-05 | 35 | 129 | 4 | CID000643668 | |
| Drug | ixabepilone | 4.54e-05 | 69 | 129 | 5 | CID006445540 | |
| Drug | AC1O5Y0F | 5.62e-05 | 37 | 129 | 4 | CID006442852 | |
| Drug | DTAF | 5.62e-05 | 37 | 129 | 4 | CID000123934 | |
| Drug | albendazole | 5.62e-05 | 37 | 129 | 4 | CID000002082 | |
| Drug | baccatin III | 5.62e-05 | 37 | 129 | 4 | CID000065366 | |
| Drug | gnoscopine | 6.25e-05 | 38 | 129 | 4 | CID000004544 | |
| Drug | laulimalide | 6.25e-05 | 38 | 129 | 4 | CID006918457 | |
| Drug | colchiceine | 6.25e-05 | 38 | 129 | 4 | CID000010156 | |
| Drug | erianin | 6.94e-05 | 39 | 129 | 4 | CID000356759 | |
| Disease | microlissencephaly (implicated_via_orthology) | 1.55e-16 | 8 | 124 | 7 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 1.55e-16 | 8 | 124 | 7 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 1.55e-16 | 8 | 124 | 7 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 1.61e-11 | 27 | 124 | 7 | DOID:0050453 (implicated_via_orthology) | |
| Disease | granulosa cell tumor | 5.24e-05 | 3 | 124 | 2 | C0018206 | |
| Disease | tyrosine-protein kinase TEC measurement | 1.05e-04 | 4 | 124 | 2 | EFO_0020830 | |
| Disease | Granulosa Cell Cancer | 1.74e-04 | 5 | 124 | 2 | C1567257 | |
| Disease | immunoglobulin superfamily DCC subclass member 4 measurement | 1.74e-04 | 5 | 124 | 2 | EFO_0801690 | |
| Disease | Nonorganic psychosis | 2.08e-04 | 69 | 124 | 4 | C0349204 | |
| Disease | apolipoprotein A 1 measurement | TTC39B OR5T3 IP6K3 NCK1 BRD3 PIGU MIDEAS LEPR SULF2 MGA ACOXL SP7 | 2.47e-04 | 848 | 124 | 12 | EFO_0004614 |
| Disease | Depression, Bipolar | 3.50e-04 | 79 | 124 | 4 | C0005587 | |
| Disease | Intellectual Disability | 6.21e-04 | 447 | 124 | 8 | C3714756 | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 7.71e-04 | 10 | 124 | 2 | C0268363 | |
| Disease | Abnormality of nervous system morphology | 7.71e-04 | 10 | 124 | 2 | C4022810 | |
| Disease | Psychotic Disorders | 8.86e-04 | 101 | 124 | 4 | C0033975 | |
| Disease | granulocyte percentage of myeloid white cells | 9.69e-04 | 268 | 124 | 6 | EFO_0007997 | |
| Disease | Skin Abnormalities | 1.33e-03 | 13 | 124 | 2 | C0037268 | |
| Disease | granulysin measurement | 1.77e-03 | 15 | 124 | 2 | EFO_0008144 | |
| Disease | C-X-C motif chemokine 16 measurement | 2.56e-03 | 18 | 124 | 2 | EFO_0010911 | |
| Disease | cystathionine measurement | 2.86e-03 | 19 | 124 | 2 | EFO_0010474 | |
| Disease | Cholecystitis | 2.86e-03 | 19 | 124 | 2 | HP_0001082 | |
| Disease | Manic Disorder | 3.36e-03 | 71 | 124 | 3 | C0024713 | |
| Disease | Osteogenesis imperfecta | 3.49e-03 | 21 | 124 | 2 | cv:C0029434 | |
| Disease | hemoglobin measurement, mean corpuscular hemoglobin | 3.83e-03 | 22 | 124 | 2 | EFO_0004509, EFO_0004527 | |
| Disease | Immunologic Deficiency Syndromes | 4.18e-03 | 23 | 124 | 2 | C0021051 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AYWASMRSFYEKNPS | 281 | Q96P26 | |
| EMLSKKHAAYAWPFY | 321 | Q15059 | |
| MPWYKFDDNYASLHR | 181 | Q96AK3 | |
| PFNLMKFIRSTHWEY | 246 | O00574 | |
| FKPQYHAEMCFLSWF | 61 | Q9UH17 | |
| MHYYLNNIWPAHTKI | 431 | Q6QNK2 | |
| VKKHYRLQFYMFGWT | 186 | O95674 | |
| YLWMNYSPEVSSKAY | 76 | O60306 | |
| WYLEHKYLTPMASTR | 526 | Q9NUZ1 | |
| ESPYTHWKQTVFYME | 306 | Q99873 | |
| NKHTSYISGPWFDMY | 106 | P23786 | |
| PKYIFHNFMERLWAY | 536 | Q14624 | |
| YILWNAHTQKYPMVH | 1736 | Q7Z401 | |
| HLYPAYGWVMFVAVF | 61 | Q9Y342 | |
| PVFFQHYQWSALVKM | 56 | Q6WBX8 | |
| SKTSEYHDIMYPAWT | 151 | Q8NBL1 | |
| PFGSSWVKHYCMYRK | 281 | A1A4S6 | |
| WPSLMKHYSPTDYVN | 81 | O94952 | |
| EVYAWAPKPYHKFMA | 1046 | O95819 | |
| PWYYGKVTRHQAEMA | 281 | P16333 | |
| LAYAFYVFTMKWNKH | 591 | O60721 | |
| GHYWMHQPVSFYKLK | 166 | Q8IWI9 | |
| FWCYNISVYPMLHDK | 391 | Q8NI17 | |
| WPQYVKDRIHSTYMY | 116 | Q9H3K2 | |
| SKDYEFMWNPHLGYI | 266 | P12277 | |
| FNEVFWVSMSYPALH | 726 | Q8IX03 | |
| YTFTSYYMHWVRQAP | 46 | P01743 | |
| FVPYTWNFKIMFHQF | 516 | Q2LD37 | |
| FVMWYLSLPHYNVIE | 31 | O75752 | |
| LYTHCYNWPEMKLFV | 431 | Q5VW00 | |
| WNMKYKKTTPEYVFH | 316 | Q13409 | |
| HSFLYQPDWRFMESK | 101 | P37268 | |
| SLLHSADMRPYNWSY | 126 | Q969U6 | |
| AATAVWHAYPILYMH | 491 | Q9HCI6 | |
| LIWNDHSLHEPMYYF | 46 | Q9Y5P0 | |
| IWIESSLHQPMYYFI | 51 | Q8NGJ5 | |
| KDYYWTHQARVFPYM | 926 | O96028 | |
| WSYVAKMSEPHYGHA | 426 | Q9P2J3 | |
| LIMHTLKYYYWAVNP | 616 | P50851 | |
| WKYYVLFRLSHFSMQ | 511 | Q8IUZ0 | |
| YTATGNYDIKWTMPH | 131 | Q6P1A2 | |
| WFKQHCAYTIAKYGM | 161 | Q6YN16 | |
| VSWILSPSDYKLMYF | 756 | P48357 | |
| APFRTYQAFMWALYK | 356 | Q96RT8 | |
| YTFTSYAMHWVRQAP | 46 | A0A0C4DH29 | |
| VIHKPFSEYTAWAMV | 206 | Q9NX62 | |
| RMIDFAHTTYKGYWN | 366 | Q96PC2 | |
| KYVTSAYQWMVPFLH | 926 | A2RRP1 | |
| ALYMAFFPVWNHLYR | 336 | Q9H490 | |
| YYATAYWMPAEKTVQ | 41 | Q6P4A8 | |
| SSWYTYAAMLRIYKH | 246 | Q6P4A8 | |
| PAHFSWKESYYRSTM | 26 | Q9H3D4 | |
| NEWTYVAKMSEPHYG | 466 | Q9P2N7 | |
| FQKLAKVYSYAHGWM | 251 | P15169 | |
| IMNHNPWMLLYFISF | 1506 | O43497 | |
| MPGLYFSKTQWEFTH | 166 | P32246 | |
| SKAMLHLQWPYKYNN | 821 | P06756 | |
| NPKEHMTLRDYITYW | 151 | Q9H9V9 | |
| AKFALVFPLMYHTWN | 116 | Q99643 | |
| RLWYKNFLEPHASMY | 86 | Q5VWK5 | |
| MDDYKSHVYIAWNLP | 406 | Q6IS24 | |
| YKVKHVVYPTAWMNQ | 261 | P43251 | |
| HPESYHSYMWNNFFK | 81 | Q8TDQ7 | |
| YVVMQASKPKYYFAW | 286 | Q6ZNC8 | |
| SDRYPSYSFKHCWKM | 746 | P10911 | |
| PLATYHYTGSDQWKM | 821 | Q6PJG2 | |
| LYTHCYNWPEMKLFV | 431 | Q5VU92 | |
| PSWLENMAYEHHYKG | 566 | O15523 | |
| WNYMYSKQPSVFVKS | 691 | Q16099 | |
| KYPSYIHKMVIWGAN | 151 | Q86WA6 | |
| YHMPNWFGTTKYVKP | 331 | O43405 | |
| FYILQWKFHSMPACA | 631 | Q92503 | |
| TWHYDPNMTCDYVIK | 646 | P42702 | |
| QMCYHLALPWYSKYF | 151 | Q7L1W4 | |
| EDSWLHNPMYYFLSV | 81 | Q8NGG3 | |
| WYPNHHTYAELMQTL | 51 | Q9Y291 | |
| HLSWSAYMYYLKHFI | 1646 | O75691 | |
| LQSYWLPNFYTHTKM | 186 | A5PLK6 | |
| MYPAYAKWVQSHRDL | 1126 | P07814 | |
| IMIKYHPKFWTDGSY | 116 | P42680 | |
| MRIFYVHAYTSKIWN | 526 | Q9H0K6 | |
| IWYKGQMTDLYHYIT | 66 | Q00889 | |
| KHPHTLSWEYYSMFQ | 436 | Q6P1X5 | |
| TFYLKFVLWMPPEHY | 331 | Q9BVG9 | |
| SYFPYKHSYMWSLSI | 51 | A6NKW6 | |
| IKDIHYMYVATGLFW | 506 | P53794 | |
| MTIWLEASLHQPLYY | 51 | Q8NH54 | |
| MKTEYLAFWLNEPHF | 201 | Q9C0C4 | |
| KITYKNFYCPFFMTW | 186 | A4IF30 | |
| WYTKQYKPSASNAFM | 421 | Q6UX06 | |
| WVLQTYHPEYMKSPL | 221 | O75783 | |
| ADWFSSMPFQKHVYY | 6 | Q86YF9 | |
| SSPWYLNFYKQTMDL | 146 | Q7Z7C7 | |
| WYMSRLLHQYAKAIF | 371 | Q96SE0 | |
| SYLSMWLHQPYVESD | 181 | Q9BW66 | |
| FLPIHITYAAMDYHW | 91 | Q99788 | |
| VAHWNIAKSMAGYYQ | 331 | O94762 | |
| DLMYAKRAFVHWYVG | 396 | P0DPH8 | |
| YMAPEVWEGHYTAKA | 421 | Q8TDR2 | |
| VEIYAWAPKPYHKFM | 1166 | Q9UKE5 | |
| WAKESMYHALGYSTI | 161 | Q5VTQ0 | |
| YIYINKEMRSSWPTH | 141 | Q6QAJ8 | |
| YTSLDMTHPYGSWYK | 126 | Q8TDD2 | |
| YVYHSSKWMVAGNAD | 201 | O95935 | |
| MQKHYTVAWFLYSAP | 1 | A6NNV3 | |
| EKNYNMYIFPVHWQF | 221 | P09486 | |
| QLSKMFFTTKHRWYP | 111 | Q9Y6G3 | |
| FKKNYHMYVYPVHWQ | 581 | Q14515 | |
| HMYVYPVHWQFSELD | 586 | Q14515 | |
| MQKHYTVAWFLYSAP | 1 | Q8NFV5 | |
| DLMYAKRAFVHWYVG | 396 | P0DPH7 | |
| WPMLSIFFTEYKYHI | 191 | P53804 | |
| WKHLSSSNVMPFNLY | 2436 | Q6N022 | |
| YFFSSMTHVLPWAYC | 206 | P48067 | |
| WSIYIDRHVMQPYYK | 776 | P78527 | |
| SYGISPQAKQWFSMY | 211 | Q68CL5 | |
| WFSMYKPITYNTNLL | 221 | Q68CL5 | |
| ISAMYFYHKLLQWSK | 1366 | Q8N9V7 | |
| HGYISASDWPLMIFY | 206 | Q96K49 | |
| LVMFYYFAQHLWPEQ | 11 | Q03924 | |
| PEHYVDYTYMATKLW | 1336 | Q96JM2 | |
| MQKHYTVAWFLYSAP | 1 | A6NJR5 | |
| DLMYAKRAFVHWYVG | 396 | Q71U36 | |
| SKHYPLYSLNVASMW | 371 | Q9NRG4 | |
| DLMYAKRAFVHWYVG | 396 | P68363 | |
| YYMFASFQSELPWKN | 141 | Q9UN76 | |
| TPSYNYAPNMDKHWI | 246 | Q8IWU6 | |
| LWAMYHVCSKNPSKY | 691 | Q6WRX3 | |
| WMQVSKRYQCHYVLP | 736 | Q6ZQQ6 | |
| DLMYAKRAFVHWYVG | 396 | Q9BQE3 | |
| LNKWIYVYHGFPNMS | 31 | Q7Z769 | |
| NYAPNPDKHWIMRYT | 251 | Q8IWU5 | |
| DLMYAKRAFVHWYVG | 396 | Q9NY65 | |
| DLMYAKRAFVHWYVG | 396 | P68366 | |
| AIMAVVWKKGLHSYY | 306 | Q8IU80 | |
| YKMTCEYTWPNHLLG | 651 | B0I1T2 |